Advertisement

Topics

NewLeaf Symbiotics, Inc. Company Profile

15:34 EDT 21st September 2017 | BioPortfolio

NewLeaf Symbiotics is a development stage company based in the Bio-Research & Development Growth (BRDG) Park at the Danforth Plant Science Center in St. Louis, MO. Formerly known as TrophoMax LLC, NewLeaf is commercializing Pink Pigmented Facultative Methylotrophs (PPFMs) for broad applications to the agriculture and horticulture industries. PPFMs are microorganisms that supply several essential nutrients that all plants need to grow. When PPFMs are applied to plants in a prescribed manner, the plants have been shown to grow faster and stronger, and to generate higher yields. Utilizing symbiotic microorganisms such as PPFMs to enhance plant growth and health can reduce the need for synthetic chemicals and other treatments, resulting in more profitable and sustainable farming.


News Articles [3 Associated News Articles listed on BioPortfolio]

Company Profile for NewLeaf Symbiotics

NewLeaf Symbiotics is a venture-funded agricultural biologicals company engaged in discovery, development, production, and commercialization of products containing beneficial plan...

Ag Biotech Company NewLeaf Symbiotics Announces $24MM C Round Financing

New capital will support expansion and product commercialization Read more...

Agriculture Biologicals Company NewLeaf Symbiotics Announces Second Close to Complete its $30MM C Round Financing

New capital reflects company’s leadership in consumer driven desire for sustainability NewLeaf Symbiotics announced that it has completed the second close of its ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Symbiotics to Prevent Postoperative Infection in Colorectal Cancer

This is a double blind randomized trial in which patients with colorectal cancer undergoing surgery will be selected to receive either a symbiotic formulation or placebo. The researchers w...

Use of Symbiotics to Reduce Urinary Oxalate Excretion

Aim # 1: Determine the effect of two probiotic preparations (AKSB and Oxadrop) on urinary oxalate excretion in two well-defined groups of patients with enteric hyperoxaluria. Our hypothes...

Companies [1 Associated Companies listed on BioPortfolio]

NewLeaf Symbiotics, Inc.

NewLeaf Symbiotics is a development stage company based in the Bio-Research & Development Growth (BRDG) Park at the Danforth Plant Science Center in St. Louis, MO. Formerly known ...

More Information about "NewLeaf Symbiotics, Inc." on BioPortfolio

We have published hundreds of NewLeaf Symbiotics, Inc. news stories on BioPortfolio along with dozens of NewLeaf Symbiotics, Inc. Clinical Trials and PubMed Articles about NewLeaf Symbiotics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NewLeaf Symbiotics, Inc. Companies in our database. You can also find out about relevant NewLeaf Symbiotics, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record